Related Experiment Video
Updated: May 2, 2026
18:08
Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation
Published on: December 31, 2007
9.4K
Unmet needs in autoimmunity and potential new tools.
1Department of Dermatology, Hunan Key Laboratory of Medical Epigenetics, Second Xiangya Hospital, Central South University, #139 Renmin Middle Rd, Changsha, Hunan, 410011, People's Republic of China, qianlu5860@gmail.com.
Clinical Reviews in Allergy & Immunology
|March 6, 2014
Summary
Autoimmunity occurs when the immune system mistakenly attacks the body, leading to autoimmune diseases (AIDs). Research is advancing understanding of AIDs mechanisms for better diagnosis and treatment.
Area of Science:
- Immunology
- Pathology
- Genetics
Background:
- Autoimmunity involves the loss of self-tolerance, leading to immune cells attacking the body.
- Autoimmune diseases (AIDs) encompass over 70 disorders, affecting 5-8% of the global population.
- AIDs are classified as organ-specific or systemic, with complex underlying mechanisms.
Purpose of the Study:
- To review the current understanding of autoimmune disease pathogenesis.
- To highlight the roles of genetic, environmental, and epigenetic factors.
- To discuss emerging biomarkers and therapeutic strategies for AIDs.
Main Methods:
- Review of scientific literature on autoimmunity and autoimmune diseases.
- Analysis of molecular mechanisms including immune cell activation and cytokine signaling.
- Synthesis of information on genetic, epigenetic, and environmental influences.
Main Results:
- Autoimmunity results from a breakdown in self-tolerance, aberrant immune cell activation, and autoantibody production.
- Genetic predisposition, environmental factors, epigenetic alterations, and molecular mimicry contribute to AIDs.
- Progress in understanding AIDs mechanisms offers potential for new biomarkers and treatments.
Conclusions:
- Elucidating autoimmune disease mechanisms is crucial for developing effective diagnostic and therapeutic tools.
- Despite advancements, challenges persist in the clinical application of novel biomarkers and therapies for AIDs.
- Future research holds promise for improving the prediction, diagnosis, prognosis, and treatment of autoimmune diseases.
